Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA

·4 min read
Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA

Mega-blockbuster Dupixent was just given the FDA's green light to treat patients with a chronic, progressive inflammatory disease.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting